Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Semplicini

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Neurology and Neuroscience Reports|October 18, 2011
Enzyme replacement therapy for Pompe diseaseCorrado Angelini, Claudio Semplicini
Current Opinion in Pharmacology|April 2, 2010
Metabolic myopathies: the challenge of new treatmentsCorrado Angelini, Claudio Semplicini
Therapeutic Advances in Neurological Disorders|September 3, 2013
Therapeutic advances in the management of Pompe disease and other metabolic myopathiesCorrado Angelini, Anna Chiara Nascimbeni, Claudio Semplicini
Journal of Neuromuscular Diseases|May 24, 2024
ExoBand, A Passive Wearable Device as a Walking Aid in Neuromuscular Patients: First Quantitative AssessmentClaudio Semplicini, Michela Agostini, Cinzia Andrigo, et al.
Journal of Neurology|May 2, 2013
Clinical phenotype, muscle MRI and muscle pathology of LGMD1FEnrico Peterle, Marina Fanin, Claudio Semplicini, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2010
Progress in Enzyme Replacement Therapy in Glycogen Storage Disease Type IICorrado Angelini, Claudio Semplicini, Paola Tonin, et al.
Neuro-Degenerative Diseases|February 25, 2011
Spinal cord herniation: a missing piece in the pathogenesis of amyotrophic lateral sclerosis and multiple sclerosis?Renzo Manara, Valentina Citton, Lucia Nardetto, et al.
Brain : a Journal of Neurology|March 24, 2017
High intra-familiar clinical variability in MORC2 mutated CMT2 patientsClaudio Semplicini, Elisabeth Ollagnon-Roman, Sarah Leonard-Louis, et al.
Lung|July 11, 2013
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependencyAndrea Vianello, Claudio Semplicini, Luciana Paladini, et al.
Scientific Reports|September 2, 2016
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathiesLuca Bello, Paola Campadello, Andrea Barp, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Neurology and Neuroscience Reports|October 18, 2011
Enzyme replacement therapy for Pompe diseaseCorrado Angelini, Claudio Semplicini
Current Opinion in Pharmacology|April 2, 2010
Metabolic myopathies: the challenge of new treatmentsCorrado Angelini, Claudio Semplicini
Therapeutic Advances in Neurological Disorders|September 3, 2013
Therapeutic advances in the management of Pompe disease and other metabolic myopathiesCorrado Angelini, Anna Chiara Nascimbeni, Claudio Semplicini
Journal of Neuromuscular Diseases|May 24, 2024
ExoBand, A Passive Wearable Device as a Walking Aid in Neuromuscular Patients: First Quantitative AssessmentClaudio Semplicini, Michela Agostini, Cinzia Andrigo, et al.
Journal of Neurology|May 2, 2013
Clinical phenotype, muscle MRI and muscle pathology of LGMD1FEnrico Peterle, Marina Fanin, Claudio Semplicini, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2010
Progress in Enzyme Replacement Therapy in Glycogen Storage Disease Type IICorrado Angelini, Claudio Semplicini, Paola Tonin, et al.
Neuro-Degenerative Diseases|February 25, 2011
Spinal cord herniation: a missing piece in the pathogenesis of amyotrophic lateral sclerosis and multiple sclerosis?Renzo Manara, Valentina Citton, Lucia Nardetto, et al.
Brain : a Journal of Neurology|March 24, 2017
High intra-familiar clinical variability in MORC2 mutated CMT2 patientsClaudio Semplicini, Elisabeth Ollagnon-Roman, Sarah Leonard-Louis, et al.
Lung|July 11, 2013
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependencyAndrea Vianello, Claudio Semplicini, Luciana Paladini, et al.
Scientific Reports|September 2, 2016
Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathiesLuca Bello, Paola Campadello, Andrea Barp, et al.
Pageof 5